Development of automated metabolite control using mid-infrared probe for bioprocesses and vaccine manufacturing
Journal of Industrial Microbiology and Biotechnology · 09.01.2024 · 51
DOI: 10.1093/jimb/kuae019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Industrial Microbiology and Biotechnology, online erschienen am 11.06.2024. Verfasst von Jennifer Reid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Global Bioprocess Development, Sanofi, Toronto, ON M2R 3T4, Canada. Hauptthemen laut MEDLINE: Bioreactors, Fermentation, Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi Vaccines.
Abstract (Originalsprache)
Automation of metabolite control in fermenters is fundamental to develop vaccine manufacturing processes more quickly and robustly. We created an end-to-end process analytical technology and quality by design-focused process by replacing manual control of metabolites during the development of fed-batch bioprocesses with a system that is highly adaptable and automation-enabled. Mid-infrared spectroscopy with an attenuated total reflectance probe in-line, and simple linear regression using the Beer-Lambert Law, were developed to quantitate key metabolites (glucose and glutamate) from spectral data that measured complex media during fermentation. This data was digitally connected to a process information management system, to enable continuous control of feed pumps with proportional-integral-derivative controllers that maintained nutrient levels throughout fed-batch stirred-tank fermenter processes. Continuous metabolite data from mid-infrared spectra of cultures in stirred-tank reactors enabled feedback loops and control of the feed pumps in pharmaceutical development laboratories. This improved process control of nutrient levels by 20-fold and the drug substance yield by an order of magnitude. Furthermore, the method is adaptable to other systems and enables soft sensing, such as the consumption rate of metabolites. The ability to develop quantitative metabolite templates quickly and simply for changing bioprocesses was instrumental for project acceleration and heightened process control and automation. One-Sentence Summary Intelligent digital control systems using continuous in-line metabolite data enabled end-to-end automation of fed-batch processes in stirred-tank reactors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Global Bioprocess Development, Sanofi, Toronto, ON M2R 3T4, Canada.
- Analytical Sciences, Sanofi, Toronto, ON M2R 3T4, Canada.
- Mettler Toledo, Columbia, MD 21046, USA.
ORCID-Profile: Jennifer Reid
Förderung
- Sanofi Vaccines
Zitieren
APA
Reid, J., Haer, M., Chen, A., Adams, C., Lin, Y. C., Cronin, J., Yu, Z., Kirkitadze, M., & Yuan, T. (2024). Development of automated metabolite control using mid-infrared probe for bioprocesses and vaccine manufacturing. Journal of Industrial Microbiology and Biotechnology, 51. https://doi.org/10.1093/jimb/kuae019
Vancouver
Reid J, Haer M, Chen A, Adams C, Lin YC, Cronin J, et al. Development of automated metabolite control using mid-infrared probe for bioprocesses and vaccine manufacturing. Journal of Industrial Microbiology and Biotechnology. 2024;51. doi:10.1093/jimb/kuae019
BibTeX
@article{Reid2024,
author = {Reid, Jennifer and Haer, Manjit and Chen, Airong and Adams, Calvin and Lin, Yu Chen and Cronin, Jim and Yu, Zhou and Kirkitadze, Marina and Yuan, Tao},
title = {Development of automated metabolite control using mid-infrared probe for bioprocesses and vaccine manufacturing},
journal = {Journal of Industrial Microbiology and Biotechnology},
year = {2024},
volume = {51},
doi = {10.1093/jimb/kuae019}
}
EUVIMED